These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36181127)

  • 1. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
    Jin A; Lin X; Yin X; Cui Y; Ma L
    Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of MTV and TLG of
    Wen W; Piao Y; Xu D; Li X
    Contrast Media Mol Imaging; 2021; 2021():7528971. PubMed ID: 34887713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
    Rijo-Cedeño J; Mucientes J; Álvarez O; Royuela A; Seijas Marcos S; Romero J; García-Berrocal JR
    Head Neck; 2020 Dec; 42(12):3744-3754. PubMed ID: 32914474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
    Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.
    Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M
    Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Rijo-Cedeño J; Mucientes J; Seijas Marcos S; Romero J; Royuela A; Carbonell S; Benlloch R; García-Berrocal JR
    Head Neck; 2021 Aug; 43(8):2477-2487. PubMed ID: 33955080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of initial [ 18 F]FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma.
    Elahmadawy MA; Ashraf A; Moustafa H; Kotb M; Abd El-Gaid S
    Nucl Med Commun; 2023 Jul; 44(7):653-662. PubMed ID: 37038954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis.
    Zheng X; Shi Y; Kulabieke D; Wang Z; Cheng Y; Qian J
    BMC Med Imaging; 2024 Jan; 24(1):9. PubMed ID: 38166643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.
    Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of the
    Wakisaka R; Kumai T; Komatsuda H; Yamaki H; Kono M; Sato R; Ohara K; Kishibe K; Hayashi T; Okizaki A; Takahara M
    Clin Otolaryngol; 2024 Nov; 49(6):733-741. PubMed ID: 38950901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of volumetric 4'-[methyl-
    Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
    Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Value of Volume-Based Metabolic Parameters of
    Han S; Kim H; Kim YJ; Suh CH; Woo S
    AJR Am J Roentgenol; 2018 Nov; 211(5):1112-1121. PubMed ID: 30207790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L; Mucientes-Rasilla J; San-Frutos Llorente LM; Royuela A; Garcia-Espantaleón Navas M; Herrero Gámiz S; Pérez-Medina T
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):17-21. PubMed ID: 30366731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
    Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
    Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.